[Ototoxicity of desferrioxamine in hemodialyzed patients].
A prospective study performed on 37 patients with end-stage renal disease who required treatment with deferoxamine is presented. Three patients presented a sudden sensorineural hearing loss, with tinnitus in one case, which was demonstrated to be of cochlear origin. All patients recovered auditory function completely after treatment was discontinued.
Sabater
F
F
Cases
A
A
Deola
M D
MD
López-Pedret
J
J
Traserra
J
J
Revert
L
L
D000328:Adult; D000368:Aged; D003676:Deferoxamine / Q000009:adverse effects*; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects*
D003676:Deferoxamine
Ototoxicidad por desferrioxamina en pacientes hemodializados.